SNAP-8
A topical peptide marketed as 'Botox in a bottle' — it reduces expression wrinkles by partially blocking the signals that tell facial muscles to contract. A non-invasive alternative to Botox injections, though with milder effects. One of the most popular cosmetic peptides, widely used in premium anti-aging skincare. People use it to soften forehead lines, crow's feet, and frown lines without needles.
Dosage
Topical: 3-10% concentration 1-2x daily on wrinkle-prone areas
Dosages shown are for research reference only. Always consult a qualified healthcare provider.
Administration
Topical (serum or cream)

Shop Research-Grade Peptides
99%+ purity · US-based · third-party lab tested
Getting Started — Here's What You'll Need
Effects
Wrinkle Reduction
Partially inhibits SNARE complex to soften expression wrinkles over 4-8 weeks.
Anti-Aging
Softens expression lines over 4-8 weeks with a topical-only, very safe approach.
Mechanism of Action
SNAP-8 (acetyl octapeptide-3) is a synthetic peptide that mimics the N-terminal end of SNAP-25, one of three proteins that form the SNARE complex — the molecular machinery required for neurotransmitter release at the neuromuscular junction. The SNARE complex consists of SNAP-25, syntaxin-1 (both on the presynaptic membrane), and VAMP/synaptobrevin (on the synaptic vesicle). These three proteins zipper together to bring the vesicle membrane into close apposition with the presynaptic membrane, enabling vesicle fusion and acetylcholine release.
SNAP-8 competes with endogenous SNAP-25 for incorporation into the SNARE complex. When SNAP-8 is incorporated instead of the native SNAP-25, the resulting complex is non-functional — it cannot complete the membrane fusion event required for acetylcholine release. By reducing the pool of functional SNARE complexes, SNAP-8 partially inhibits acetylcholine release at the neuromuscular junction, decreasing the intensity of muscle contraction. This weakened contraction softens the dynamic wrinkles formed by repeated facial expressions (forehead lines, crow's feet, glabellar lines).
The critical distinction from botulinum toxin is the degree of inhibition. Botulinum toxin proteolytically cleaves SNARE proteins (botulinum serotype A cleaves SNAP-25 irreversibly), completely preventing neurotransmitter release and producing true flaccid paralysis of the target muscle for 3-6 months. SNAP-8, applied topically, only partially competes with SNAP-25 at whatever concentration penetrates the stratum corneum. Skin penetration of peptides is inherently limited, so the effective concentration reaching the neuromuscular junction is far below what would be needed for complete SNARE inhibition. The result is a mild, reversible relaxation of superficial facial muscles — sufficient to soften fine lines with regular use but nowhere near the dramatic effect of injected botulinum toxin.
Regulatory Status
Sold as a cosmetic ingredient. Not FDA approved as a drug. Widely available in skincare products. Manufactured by Lipotec/Lubrizol.
Risks & Safety
Common
mild skin irritation, temporary redness.
Rare
contact dermatitis, allergic reaction to formulation ingredients.
Compare SNAP-8 With
Research Papers
60Published: February 7, 2026
AI Summary
Researchers developed a peptide-based fluorescent probe that detects heparin with exceptional sensitivity in under 30 seconds, even in living cells and zebrafish. The probe works by forming nanoaggregates with heparin and could enable portable, point-of-care testing for patients on anticoagulant therapy.
Published: February 12, 2026
AI Summary
A deep learning model was built and validated to predict short-term death risk in heart failure patients using ECG data. With heart failure mortality rising again after years of decline, such tools could help clinicians identify high-risk patients who need more intensive care.
Published: February 11, 2026
AI Summary
A new copper-catalyzed method enables the creation of chiral nitrogen-containing compounds from amino carbonyls in a way that works with peptides. The approach uses an unconventional reaction pathway that could expand options for synthesizing drug-like molecules.
Published: February 11, 2026
AI Summary
Scientists identified a new type of sugar-derived cross-link called MIDAL that forms between arginine residues and can become the dominant age-related modification in certain proteins. Understanding these cross-links matters because they are linked to many age-related diseases and may be reversible.
Published: February 5, 2026
AI Summary
Artemisia scoparia essential oil is known to have antioxidant and anti-inflammatory properties, but how it works remains poorly understood. The abstract frames the need for further research into its mechanisms.
Published: February 11, 2026
AI Summary
The protein Etv3 was identified as a key regulator that keeps dendritic cells in a tolerance-promoting state. When Etv3 was removed in mice, autoimmune-like disease worsened, suggesting it may be relevant to human conditions like lupus.
Published: February 11, 2026
AI Summary
Engineering mosquito gut bacteria to produce anti-malarial peptides can block parasite development by up to 98% in some setups. The approach could complement existing malaria control, though safety and field testing remain hurdles before wider use.
Published: February 11, 2026
AI Summary
GLP-1 drugs show promise in lab models of ALS but current clinical data do not support their use and raise safety concerns, especially around weight loss. More ALS-specific trials are needed before considering these drugs for this population.
Published: February 11, 2026
AI Summary
Blocking the VEGF-C-Flt4 pathway reduced brain swelling in rats after stroke by limiting activation of meningeal lymphatic cells. Targeting this pathway could offer a new way to reduce stroke-related inflammation and edema.
Published: February 11, 2026
AI Summary
In rats with kidney injury, Remdesivir worsened damage by reducing mitochondrial biogenesis and increasing cell death, especially when given subcutaneously. The findings support caution when using Remdesivir in patients with impaired kidney function.
Published: February 11, 2026
AI Summary
Weight-loss drugs that mimic GLP-1 mainly reduce appetite but do little to boost energy expenditure. Glucagon receptor agonists may help by increasing fat burning and metabolic rate, potentially improving long-term weight loss when combined with GLP-1 drugs.
Published: February 11, 2026
AI Summary
Combining Fu brick tea extract with millet reduced obesity in mice by improving digestion, shifting gut bacteria, and increasing satiety signals. The combination could inform development of starch-based foods that support metabolic health.
Published: February 11, 2026
AI Summary
A rice-derived peptide called PHP1 was identified, produced in bacteria, and shown to reduce inflammation in cells and mice by blocking NF-κB. The work supports scalable production of anti-inflammatory peptides for functional foods.
Published: February 11, 2026
AI Summary
A one-step method was developed to attach four drug molecules to antibodies with high uniformity. The resulting antibody-drug conjugates showed strong tumor suppression and good stability, advancing options for cancer treatment.
Published: February 11, 2026
AI Summary
Combining a CD4-mimic molecule with a neutralizing antibody into a single conjugate improved anti-HIV activity compared to using both separately. The approach could inform new HIV treatment strategies, though antibody-dependent immune cell killing was reduced.
Published: February 11, 2026
AI Summary
GLP-1 drugs like semaglutide are widely used for diabetes and weight loss, but emerging reports suggest a possible link to a rare form of vision loss. The abstract highlights the need to weigh this potential risk.
Published: December 11, 2026
AI Summary
The allergy drug loratadine restored the effectiveness of colistin against resistant bacteria by blocking a key resistance mechanism. Repurposing existing drugs alongside antibiotics could help combat drug-resistant infections.
Published: February 11, 2026
AI Summary
The Sim-Q questionnaire was developed to measure how simple or complex diabetes treatment feels to patients. The study evaluated whether the questionnaire is reliable and valid for use in type 2 diabetes.
Published: February 11, 2026
AI Summary
Long-term follow-up of Japanese patients receiving peptide receptor radionuclide therapy for neuroendocrine tumors was analyzed for survival and safety. The work addresses gaps in knowledge about durable outcomes of this treatment.
Published: February 11, 2026
AI Summary
A mathematical model showed that how quickly the body clears infliximab strongly affects treatment success in inflammatory bowel disease. The model could support personalized dosing and drug monitoring to improve outcomes.
Published: February 11, 2026
AI Summary
Obesity caused by hypothalamic damage is hard to treat with diet and exercise alone, but newer drugs targeting appetite and metabolism show promise. Combination therapies may eventually reduce the need for bariatric surgery in this population.
Published: February 11, 2026
AI Summary
NOD2 is an immune sensor whose gene variants are linked to several diseases. The review summarizes what is known about these conditions and the biological roles of NOD2.
Published: February 11, 2026
AI Summary
Kuwaiti experts recommend earlier screening, better coordination across specialties, and broader use of GLP-1 drugs to address the overlapping burdens of obesity, diabetes, heart disease, and kidney disease. Semaglutide was highlighted as a valuable option.
Published: February 11, 2026
AI Summary
A small RNA called miR-7052 helps protect the blood-brain barrier during sepsis by suppressing two proteins that promote leakage. Restoring or mimicking miR-7052 could be a strategy to limit brain damage in severe infection.
Published: February 11, 2026
AI Summary
A fusion vaccine combining antigens from latent and active tuberculosis triggered stronger immune responses than single antigens in infected people and mice. Both protein and DNA versions of the vaccine showed robust immunogenicity.
Published: February 11, 2026
AI Summary
Genes that spread colistin resistance among bacteria have evolved into multiple variants and pose a growing threat. The review covers how these genes work, how they spread, and potential countermeasures including surveillance and new inhibitors.
Published: February 11, 2026
AI Summary
Four shellfish species were digested in the lab to compare their peptide profiles and potential bioactive effects. The abstract describes the study design without reporting conclusions.
Published: February 11, 2026
AI Summary
A bacterial peptide called microcin H47 killed triple-negative breast cancer cells while sparing normal cells, largely through apoptosis. The findings support further development of this peptide as a potential cancer treatment.
Published: February 10, 2026
AI Summary
A vaccine targeting 209 frameshift peptides produced strong, broad, and durable immune responses in people with Lynch syndrome. The approach could help prevent the multiple cancer types these individuals are at higher risk of developing.
Published: February 5, 2026
AI Summary
During fasting, muscle proteins undergo widespread modification by a ketone-derived tag that may help regulate metabolism. The work reveals how muscle adapts to starvation at the molecular level.
Published: February 11, 2026
AI Summary
The study examined how long-acting insulin analogs affect the ability to measure natural insulin and C-peptide production in the body. Understanding this matters for distinguishing type 1 from type 2 diabetes when patients are already on insulin.
Published: February 11, 2026
AI Summary
Merkel cells in the vagina may have mechanosensory roles similar to those in skin, but their function there is still unclear. The study aimed to characterize these cells and their potential roles.
Published: February 11, 2026
AI Summary
Blocking the NLRP3 inflammasome could offer a new gene therapy approach for Parkinson's, given its role in neuroinflammation. The abstract outlines this rationale without detailing study outcomes.
Published: February 11, 2026
AI Summary
A new model was developed to predict serious heart complications after surgery for bile duct cancer using preoperative cardiac ultrasound. The tool could help identify high-risk patients before surgery.
Published: February 12, 2026
AI Summary
Innate lymphoid cells can either worsen or dampen multiple sclerosis depending on subtype and context. Understanding and targeting these cells may lead to more precise treatments for MS.
Published: February 11, 2026
AI Summary
A cytomegalovirus protein activates itself using a built-in peptide, which helps the virus hijack host cell signaling. Understanding this mechanism could inform new antiviral strategies.
Published: February 11, 2026
AI Summary
A peptide that disrupts a three-protein complex in kidney cancer cells slowed tumor growth and spread in lab models. The findings point to a potential new target for kidney cancer therapy.
Published: February 11, 2026
AI Summary
Abstract too short to summarize.
Published: February 11, 2026
AI Summary
Abstract too short to summarize.
Published: February 11, 2026
AI Summary
Only a small subset of VIP neurons in the brain's clock region responds to vasopressin, and this response helps maintain robust daily rhythms. The work maps how different neuron types communicate within the circadian clock.
Published: February 11, 2026
AI Summary
Gene expression in immune cells was mapped in response to different stimuli and genetic perturbations. The dataset helps clarify which transcription factors drive inflammatory responses and how drugs might alter them.
Published: February 11, 2026
AI Summary
FDA and industry experts met to discuss how to assess immunogenicity risk for generic peptides and oligonucleotides. The workshop aimed to improve regulatory frameworks for these complex products.
Published: February 12, 2026
AI Summary
Most secreted and membrane proteins in human cells depend on the signal recognition particle for proper delivery. The work also identified compensatory pathways and quality control mechanisms when this system is impaired.
Published: February 11, 2026
AI Summary
A protein called SerpinB2 helps fat tissue macrophages survive by supporting mitochondrial function. Obesity reduces SerpinB2, contributing to metabolic dysfunction, but restoring it or giving a glutathione precursor improved metabolic health in mice.
Published: February 11, 2026
AI Summary
A new method called PRICE detects tiny differences in miRNA sequences with high sensitivity, which could improve cancer diagnosis and prognosis. The approach uses peptide nucleic acid blockers with CRISPR to distinguish closely related miRNAs.
Published: February 11, 2026
AI Summary
Staphylococcus aureus uses a distinct mechanism to start protein synthesis that differs from other bacteria. A small leader peptide was also found to control biofilm formation by linking nutrient availability to gene expression.
Published: February 11, 2026
AI Summary
Loss of estrogen after menopause turns on a sialylation pathway in bone-eating cells that accelerates bone loss. Blocking this pathway with a sialidase reduced bone loss in mice, suggesting a potential therapeutic target for osteoporosis.
Published: February 12, 2026
AI Summary
An aptamer that binds a conserved coronavirus protein blocked inflammation across multiple coronaviruses. A combined aptamer-antisense construct reduced viral load and lung inflammation in mice, offering a template for future pandemic preparedness.
Published: February 11, 2026
AI Summary
Chiral gold nanoparticles guided by peptides catalyzed the formation of mirror-image polymers with different cancer-killing effects. The approach could support development of chirality-selective cancer therapies.
Published: February 12, 2026
AI Summary
A case of a child with familial hypercholesterolemia despite statin therapy prompts a discussion of current options for early diagnosis and treatment. The abstract frames questions about safety and effectiveness in pediatric patients.
Published: February 12, 2026
AI Summary
Newer cortisol assays may require a lower cutoff than the traditional 18 μg/dL for diagnosing adrenal insufficiency. The study evaluated whether a revised threshold of 15.6 μg/dL improves diagnostic accuracy.
Published: February 12, 2026
AI Summary
Rolling out flash glucose monitoring for adults with type 2 diabetes on intensive insulin poses organizational challenges for health systems. The abstract introduces this topic without reporting outcomes.
Published: February 12, 2026
AI Summary
Oncostatin M and leukemia inhibitory factor are linked to muscle loss in malnutrition. The study aimed to determine their role in sarcopenia in cancer patients with malnutrition.
Published: April 14, 2026
AI Summary
A sugar fragment from a traditional herb boosted immune function and repaired gut barrier damage in immunosuppressed mice. The work supports development of immunomodulatory products from this plant.
Published: April 14, 2026
AI Summary
A sugar from a Chinese medicinal plant extended lifespan and reduced aging-related decline in worms and mice by dampening insulin/IGF-1 signaling. The findings support exploration of this compound for anti-aging applications.
Published: April 14, 2026
AI Summary
Yeast beta-glucan and chicory inulin helped restore normal daily rhythms and reduced brain inflammation in mice with systemic inflammation. The effects were similar to melatonin and ibuprofen, suggesting prebiotics may support circadian and brain health.
Published: February 11, 2026
AI Summary
Two protein modifications that look identical by standard mass spectrometry were distinguished using chromatography and a specialized fragmentation method. The approach was used to confirm lactylation at a specific site in aldolase across cell types.
Published: February 11, 2026
AI Summary
Blocking CXCR4 with an oncolytic virus remodeled blood vessels around ovarian tumors and improved T cell infiltration and anti-tumor activity. The results support combining this approach with adoptive T cell therapy for ovarian cancer.
Published: February 11, 2026
AI Summary
At typical and higher concentrations, tramadol did not significantly affect platelet function in blood samples from healthy volunteers. The findings support the safety of tramadol regarding bleeding risk, though larger studies are needed.
Published: February 9, 2026
AI Summary
Regions of proteins that bind sugars often overlap with regions prone to aggregation, and many disease-linked mutations fall in these sites. The work refines understanding of how protein structure, sugar binding, and aggregation interact.
Frequently Asked Questions
What is SNAP-8?
A topical peptide marketed as 'Botox in a bottle' — it reduces expression wrinkles by partially blocking the signals that tell facial muscles to contract. A non-invasive alternative to Botox injections, though with milder effects. One of the most popular cosmetic peptides, widely used in premium anti-aging skincare. People use it to soften forehead lines, crow's feet, and frown lines without needles.
What is SNAP-8 used for?
A topical peptide marketed as 'Botox in a bottle' — it reduces expression wrinkles by partially blocking the signals that tell facial muscles to contract. A non-invasive alternative to Botox injections, though with milder effects. One of the most popular cosmetic peptides, widely used in premium anti-aging skincare. People use it to soften forehead lines, crow's feet, and frown lines without needles.
What is the dosage for SNAP-8?
Topical: 3-10% concentration in serums or creams, applied once or twice daily to wrinkle-prone areas (forehead, crow's feet, frown lines). Results develop gradually over 4-8 weeks of consistent use.
What are the side effects of SNAP-8?
Common: mild skin irritation, temporary redness. Rare: contact dermatitis, allergic reaction to formulation ingredients.
How does SNAP-8 work?
SNAP-8 (acetyl octapeptide-3) is a synthetic peptide that mimics the N-terminal end of SNAP-25, one of three proteins that form the SNARE complex — the molecular machinery required for neurotransmitter release at the neuromuscular junction. The SNARE complex consists of SNAP-25, syntaxin-1 (both on the presynaptic membrane), and VAMP/synaptobrevin (on the synaptic vesicle). These three proteins zipper together to bring the vesicle membrane into close apposition with the presynaptic membrane, enabling vesicle fusion and acetylcholine release. SNAP-8 competes with endogenous SNAP-25 for incorporation into the SNARE complex. When SNAP-8 is incorporated instead of the native SNAP-25, the resulting complex is non-functional — it cannot complete the membrane fusion event required for acetylcholine release. By reducing the pool of functional SNARE complexes, SNAP-8 partially inhibits acetylcholine release at the neuromuscular junction, decreasing the intensity of muscle contraction. This weakened contraction softens the dynamic wrinkles formed by repeated facial expressions (forehead lines, crow's feet, glabellar lines). The critical distinction from botulinum toxin is the degree of inhibition. Botulinum toxin proteolytically cleaves SNARE proteins (botulinum serotype A cleaves SNAP-25 irreversibly), completely preventing neurotransmitter release and producing true flaccid paralysis of the target muscle for 3-6 months. SNAP-8, applied topically, only partially competes with SNAP-25 at whatever concentration penetrates the stratum corneum. Skin penetration of peptides is inherently limited, so the effective concentration reaching the neuromuscular junction is far below what would be needed for complete SNARE inhibition. The result is a mild, reversible relaxation of superficial facial muscles — sufficient to soften fine lines with regular use but nowhere near the dramatic effect of injected botulinum toxin.
How is SNAP-8 administered?
SNAP-8 is administered via topical (serum or cream).
What is the half-life of SNAP-8?
The half-life of SNAP-8 is Not applicable (topical, not systemically absorbed).
Is SNAP-8 legal?
Sold as a cosmetic ingredient. Not FDA approved as a drug. Widely available in skincare products. Manufactured by Lipotec/Lubrizol.
Related Peptides
Botulinum Toxin
A toxin produced by bacteria — the most potent biological toxin known, yet one of the most widely used cosmetic and medical treatments globally. In carefully controlled doses, it temporarily relaxes targeted muscles by blocking the signal that tells muscles to contract. Approved for cosmetic wrinkle reduction and many medical conditions including chronic migraine, excessive sweating, and neck muscle spasms. People use it for forehead lines, crow's feet, frown lines, and various medical conditions.
GHK-Cu
A naturally occurring copper-binding peptide found throughout the body; levels drop after age 20. The most studied cosmetic peptide, with proven effects on collagen production, skin renewal, wound healing, and antioxidant protection. It influences over 4,000 genes, shifting them toward a younger, more regenerative pattern. People use it for skin aging, wound healing, and anti-aging.
Glutathione
The body's main antioxidant — present in every cell and essential for detoxification, immune function, and protection against oxidative damage. Widely used for skin brightening (it slows dark pigment production), liver support, and overall antioxidant therapy. Available as IV infusion, oral supplement, or injection. People use it for skin lightening, detox support, and anti-aging.
Hyaluronic Acid
A naturally occurring substance found in connective tissue, skin, and joint fluid throughout the body. It holds moisture, lubricates joints, and adds volume to skin. Used in many forms: injectable fillers for facial volume, joint injections for arthritis, topical serums for skin hydration, and oral supplements. Different sizes (molecular weights) have different effects. People use it for wrinkles, joint pain, and skin hydration.